Teva Pharmaceutical Industries TEVA Earnings Call Transcripts

NYSE TEVA
$42.60 +0.85 (+2.04%)
At close: Nov 6, 2026 · 4:00 PM EST
24 earnings calls on file for Teva Pharmaceutical Industries, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Teva Pharmaceutical Industries Q3 2026 Earnings Call

Nov 3, 2026 11,269 words · 49 min read
  • Christopher StevoHead of Investor Relations
  • Richard FrancisChief Executive Officer
  • Eric HughesHead of Global R&D, and Chief Medical Officer
  • Eli KalifChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Teva Pharmaceutical Industries Earnings Call Transcripts

Calls24
LatestNov 3, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 24 Teva Pharmaceutical Industries transcripts Register to get access to Teva Pharmaceutical Industries’s earnings call transcripts.